Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Bronchodilator of long-lasting action.
At latest update no published data on excretion into breast milk were found.
Terbutaline which is a compound closely related to Formoterol is excreted into breast milk in non-significant amount.
Salmeterol, another compound with similar characteristics, is also non-significantly excreted.
With a relatively high molecular weight, excretion into breast milk seems unlikely.
Expert consensus states that the use of inhaled bronchodilators is compatible with breastfeeding due to a minimal absorption and low levels achieved in the mother's plasma.
Inhaled therapy with bronchodilators is preferred since they use a lower dose (less likelihood of excretion into milk)